1. Diallyl trisulfide suppresses doxorubicin‐induced cardiomyocyte apoptosis by inhibiting MAPK/NF‐κB signaling through attenuation of ROS generation
   Su‐Ying Wen et al, 2018, Environmental Toxicology CrossRef
2. Aloe-emodin relieves zidovudine-induced injury in neonatal rat ventricular myocytes by regulating the p90rsk/p-bad/bcl-2 signaling pathway
   Wei Zhao et al, 2021, Environmental Toxicology and Pharmacology CrossRef
3. Synergistic effects of polydatin and vitamin C in inhibiting cardiotoxicity induced by doxorubicin in rats
   Hui‐Lin Wang et al, 2017, Fundamental & Clinical Pharmacology CrossRef
4. Hydrogen sulfide attenuates TMAO‑induced macrophage inflammation through increased SIRT1 sulfhydration
   Mi-Hua Liu et al, 2023, Molecular Medicine Reports CrossRef
5. Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity
   Shuxu Du et al, 2018, Frontiers in Pharmacology CrossRef
6. New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations
   Elisabetta Bigagli et al, 2018, Investigational New Drugs CrossRef
7. Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity
   J Wu et al, 2016, Cell Death & Disease CrossRef
8. ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
   Simona Gallo et al, 2019, International Journal of Molecular Sciences CrossRef
9. Protein S‐sulfhydration by hydrogen sulfide in cardiovascular system
   Guoliang Meng et al, 2018, British Journal of Pharmacology CrossRef
10. Exogenous hydrogen sulfide protects against high glucose‑induced apoptosis and oxidative stress by inhibiting the STAT3/HIF‑1α pathway in H9c2 cardiomyocytes
    Jing Li et al, 2019, Experimental and Therapeutic Medicine CrossRef
11. H2S Donors with Cytoprotective Effects in Models of MI/R Injury and Chemotherapy-Induced Cardiotoxicity
    Qiwei Hu et al, 2023, Antioxidants CrossRef